Follow
Jessy John
Jessy John
Post-doctoral Associate
Verified email at pitt.edu
Title
Cited by
Cited by
Year
Modulatory role of simvastatin against aluminium chloride-induced behavioural and biochemical changes in rats
M Nampoothiri, J John, N Kumar, J Mudgal, GK Nampurath, ...
Behavioural neurology 2015, 2015
1172015
Insulin blocks glutamate-induced neurotoxicity in differentiated SH-SY5Y neuronal cells
M Nampoothiri, ND Reddy, J John, N Kumar, G Kutty Nampurath, ...
Behavioural Neurology 2014, 2014
602014
Sesamol, a lipid lowering agent, ameliorates aluminium chloride induced behavioral and biochemical alterations in rats
J John, M Nampoothiri, N Kumar, J Mudgal, GK Nampurath, ...
Pharmacognosy magazine 11 (42), 327, 2015
582015
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers
SMY Chen, V Popolizio, RA Woolaver, H Ge, AL Krinsky, J John, E Danis, ...
Journal of Experimental & Clinical Cancer Research 41 (1), 123, 2022
112022
Activity of MUC1 cancer antigen-binding plasma anti-α-galactoside antibody correlates inversely with size of autologous lipoprotein (a)
J John, V Kalaivani, M Geetha, PS Appukuttan
Experimental Biology and Medicine 244 (11), 893-900, 2019
32019
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding …
J John, RA Woolaver, V Popolizio, SMY Chen, H Ge, AL Krinsky, ...
Frontiers in Immunology 13, 992630, 2022
22022
Why responses to immune checkpoint inhibitors are heterogeneous in head and neck cancers: Contributions from tumor-intrinsic and host-intrinsic factors
Z Chen, J John, JH Wang
Frontiers in Oncology 12, 995434, 2022
22022
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs
M Vashisht, H Ge, J John, HA McKelvey, J Chen, Z Chen, JH Wang
Cell Death & Disease 14 (9), 599, 2023
12023
COVID-19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID-19 infection
J John, MG Ushakumary, S Chandrasekher, S Chenicheri
Stem Cells and COVID-19, 111-124, 2022
12022
Low reactivity of tumor MUC1-binding natural anti-α-galactoside antibody is a risk factor for breast cancer
J John, K Cherian, T Abraham, PS Appukuttan
Experimental Biology and Medicine 245 (3), 254-265, 2020
12020
Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders
J John, SMY Chen, RA Woolaver, H Ge, M Vashisht, Z Chen, JH Wang
Frontiers in Immunology 14, 1009, 2023
2023
Stem cell-driven tissue regeneration as treatment for COVID-19
JJ Thomas, J John, MG Ushakumary
Stem Cells and COVID-19, 125-138, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–12